GI Endoscope is the fastest growing sector, North America is the largest market
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Market Drivers
The expansion of government-led colorectal cancer screening programs significantly propels the global surgical snares market. Public health efforts focused on early detection are leading to a higher volume of diagnostic and therapeutic endoscopies, consequently boosting demand for polypectomy devices. By mandating or subsidizing preventive screenings, healthcare systems identify more patients requiring immediate polyp removal, directly sustaining the consumption of these single-use instruments. For example, 3,617,246 patients were screened for colorectal cancer in participating health centers in 2024, as reported by the American Cancer Society National Colorectal Cancer Roundtable (August 2025).This high screening volume is crucial given that colorectal cancer was projected to cause approximately 52,900 deaths in the United States in 2025, highlighting the urgent clinical need for efficient excision tools. Concurrently, advancements in surgical snare design, such as cold snares and rotatable hybrid models, are enhancing procedural safety and efficacy, thereby increasing market value and adoption. These innovations allow endoscopists to perform complex resections with greater confidence, promoting a shift towards minimally invasive outpatient procedures. Boston Scientific's net sales of $5.07 billion in Q3 2025, representing a 20.3% year-over-year increase, validate the strong demand for advanced endoscopic technologies.
Market Challenges
A major impediment to the Global Surgical Snares Market's growth is the risk of procedural complications, such as perforation or hemorrhage, during polypectomy. These safety concerns necessitate advanced operator proficiency and create a steep learning curve, thus limiting device adoption in facilities lacking specialized training infrastructure. In developing healthcare markets, where access to skilled endoscopists is often restricted, the potential for adverse events discourages the widespread use of these electrosurgical tools, thereby hindering market expansion. A large-scale cohort study in 2025 by the American Association for Cancer Research revealed a 1.04% risk of serious complications, including hospitalization or death within 30 days, for patients undergoing screening colonoscopies, often due to procedural interventions. This data reinforces the need for high operator competency, leading healthcare providers in resource-constrained settings to potentially defer the adoption of advanced snare devices, which directly impacts the market's ability to penetrate non-specialized global regions.Market Trends
The shift of endoscopic procedures to Ambulatory Surgery Centers (ASCs) is transforming the market landscape, as healthcare providers seek more cost-effective and efficient alternatives to traditional hospitals. This operational decentralization of polyp removal services allows for quicker patient turnover and increased procedure volumes, directly fueling the demand for polypectomy devices. Evidence of this expansion in outpatient procedural volume comes from Surgery Partners' Q3 2025 earnings report, which indicated a 3.4% year-over-year increase in same-facility surgical cases, particularly in gastrointestinal services.Simultaneously, there is a growing transition towards single-use disposable snares to mitigate cross-contamination risks associated with reusable instruments. Hospitals and clinics are increasingly prioritizing infection prevention protocols, leading to a procurement shift away from capital-intensive reusable accessories in favor of sterile solutions that ensure consistent performance and patient safety. This robust demand for infection-control consumables is reflected in STERIS plc's Fiscal 2025 Fourth Quarter results, where revenue from healthcare consumables grew by 6%, highlighting the market's continued pivot towards disposable procedural tools.
Key Market Players
- Medtronic Plc
- Boston Scientific Corporation
- Medline Industries, Inc.
- Olympus Corporation
- Cook Medical Inc.
- CONMED Corporation
- Merit Medical Systems
- Avalign Technologies
- Hill-Rom Holdings, Inc.
- Sklar Surgical Instruments.
Report Scope
In this report, the Global Surgical Snares Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Surgical Snares Market, by Usability:
- Single-use
- Reusable
Surgical Snares Market, by Application:
- GI Endoscope
- Laparoscopy
- Urology Endoscopy
- Gynecology
- Endoscopy
- Arthroscopy
- Bronchoscopy
- Mediastinoscopy
- Laryngoscopy
- Others
Surgical Snares Market, by End-use:
- Hospitals
- Ambulatory Surgical Centers
- Others
Surgical Snares Market, by Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Surgical Snares Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Medtronic Plc
- Boston Scientific Corporation
- Medline Industries, Inc.
- Olympus Corporation
- Cook Medical Inc.
- CONMED Corporation
- Merit Medical Systems
- Avalign Technologies
- Hill-Rom Holdings, Inc.
- Sklar Surgical Instruments.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | May 2026 |
| Forecast Period | 2025 - 2031 |
| Estimated Market Value ( USD | $ 1.81 Billion |
| Forecasted Market Value ( USD | $ 2.66 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |


